Woodbridge, Canada

Navin Vaya

This inventor holds 1 USPTO granted patent. Top assignee: Apotex Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Navin Vaya. Retrieved from https://idiyas.com/inventor/navin-vaya-q9wyfgc8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Navin Vaya

Introduction

Navin Vaya is an accomplished inventor based in Woodbridge, CA. He has made significant contributions to the field of pharmaceuticals, particularly with his work on oxcarbazepine. His innovative approach has led to the development of a unique dosage form that enhances the efficacy of this medication.

Latest Patents

Navin Vaya holds a patent for an "Oxcarbazepine extended release dosage form." This invention relates to extended release pharmaceutical dosage forms of oxcarbazepine, which is used to treat epilepsy and bipolar disorder. His patent represents a significant advancement in the delivery of this important medication.

Career Highlights

Navin Vaya is currently employed at Apotex Inc., a leading pharmaceutical company known for its commitment to quality and innovation. His role at Apotex has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Krishna Hari Bhandari and Sandeep Patel. Their collaboration has contributed to the success of various projects within the company.

Conclusion

Navin Vaya's contributions to the pharmaceutical field, particularly through his patent on oxcarbazepine, highlight his innovative spirit and dedication to improving patient care. His work at Apotex Inc. continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…